Kimberly-Clark's Powering Care Plan: Can It Strengthen Growth?
KMB's Powering Care strategy drives innovation, productivity gains and margin expansion across key consumer categories.
KMB - Kimberly-Clark Corporation
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$103.75
DETAILS
HIGH:
$110.00
LOW:
$99.00
MEDIAN:
$103.00
CONSENSUS:
$103.75
UPSIDE:
4.65%
Stock News
PULL-UPS® DEBUTS LEARNING LAYER™ TECHNOLOGY, A NEW INNOVATION TO HELP KIDS LEARN THE DIFFERENCE BETWEEN WET AND DRY
Kylie Kelce Partners with Pull-Ups® to help Tackle the Highs, Lows and " Uh-Oh " Moments of Potty Training CHICAGO, May 19, 2026 /PRNewswire/ -- Pull-Ups®, a trusted brand and leader in potty training for nearly four decades, is proud to introduce Learning Layer™ technology, a new innovation designed to support one of parenting's most unpredictable milestones. Many potty training methods either help kids notice accidents, or contain mess, but not both – and occasionally neither.
Kimberly-Clark Declares Quarterly Dividend
DALLAS, May 14, 2026 /PRNewswire/ -- The board of directors of Kimberly-Clark Corporation (NASDAQ: KMB) has declared a regular quarterly dividend of $1.28 per share. The dividend is payable in cash on July 2, 2026, to stockholders of record at the close of business on June 5, 2026.
Kimberly-Clark positioned for long-term value creation following Kenvue deal, says Bank of America
Kimberly-Clark Corp (NYSE:KMB, XETRA:KMY) has earned a repeat ‘Buy' rating and $120 price objective from Bank of America analysts, who believe that the company's acquisition of Kenvue assets could create long-term value despite near-term integration challenges. The analysts said the deal appears opportunistic, noting the acquisition multiple of about 14 times Kenvue's last-twelve-month adjusted EBITDA and a purchase price of $21.01 per share, roughly in line with Kenvue's market value before Tylenol-related headlines weighed on the stock in September 2025.
Kimberly-Clark Corporation (KMB) Shareholder/Analyst Call Transcript
Kimberly-Clark Corporation (KMB) Shareholder/Analyst Call Transcript
These Market Signals Alarm Me, but I Still See Profit Potential in These 3 Consumer Stocks
Consumer defensive stocks with a solid dividend history could serve investors well regardless of what happens to the market.
$100,000 in Our Dividend Kings Portfolio Will Generate $5,400 in Passive Income Each Year
Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.
These 3 Dividend Stocks Have Made Investors Rich. They Can Do It Again.
Hershey is shifting from cost pressure to earnings expansion amid collapsing cocoa prices, aiding growth recovery and the dividend. General Mills offers an unusually high 7% yield because of temporary headwinds, while restructuring and its pet food segment provide a path back to stability.
Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark
Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its skin health and beauty brands.
Huggies® Launches "Natural Born Fighters" to Celebrate the Strength and Spirit of NICU Babies and Families, and the Care that Supports Their Fight
The new campaign features reigning football champion and starting linebacker Derick Hall, gold medal swimmer Allison Schmitt and others to help the world see NICU babies as the fighters they are CHICAGO, May 6, 2026 /PRNewswire/ -- Huggies® today announced the launch of Natural Born Fighters , a new campaign recognizing the strength of NICU babies and supporting the families, nurses and caregivers who fight alongside them. Grounded in the belief that every baby deserves care designed for their unique needs, the campaign builds on a powerful truth: while some see NICU babies as fragile, Huggies sees them as Little Fighters.
The Best Dividend Stock to Own During a Market Crash
This consumer staples stock should remain resilient no matter what happens with the market.
Kimberly-Clark Corporation (KMB) Presents at Barclays 18th Annual Americas Select Conference Transcript
Kimberly-Clark Corporation (KMB) Presents at Barclays 18th Annual Americas Select Conference Transcript
Exclusive: Brazil pulp giant Suzano set to win full EU nod for $3.4 billion Kimberly-Clark deal, sources say
Brazil's Suzano , the world's largest pulp maker, is set to win unconditional EU antitrust approval for its $3.4 billion joint venture with U.S. consumer goods giant Kimberly-Clark , two people with knowledge of the matter said.
I'm Buying These Dividend Aristocrat Bargains For Recurring Income
Kimberly-Clark and Hormel are attractively valued Dividend Aristocrats with strong balance sheets and yields above 5%. KMB demonstrates volume-led growth, and industry-leading productivity and expects generational value from the Kenvue integration, despite near-term oil price headwinds. HRL is pivoting toward higher-margin branded proteins, divesting low-margin businesses, and projecting 7% EPS growth at the midpoint for 2026.
6 April Raises With 1 High Yield Giving 20% And 1 Cut
The Rose Income Garden (RIG) portfolio, with 73 dividend-paying holdings, yields 6% and is up 8.21% YTD, outperforming SPY. I view KO, WPC, and XEL as quality income holdings but consider KO and WPC overvalued, maintaining them as holds, while XEL is a buy on dips. GPC and KMB are undervalued with attractive yields; I have added to both, expecting future capital gains and reliable dividends.
3 Best Consumer Staples Stocks to Buy and Hold for Decades
These consumer companies have served customers for decades, and their stocks trade at attractive levels.
Kimberly-Clark to Webcast its Presentation at the Barclays 18th Annual Americas Select Conference 2026
DALLAS, April 29, 2026 /PRNewswire/ -- Mike Hsu, Chairman and Chief Executive Officer of Kimberly-Clark Corporation (NASDAQ: KMB), and Nelson Urdaneta, Chief Financial Officer, will be featured speakers at the Barclays 18th Annual Americas Select Conference on Tuesday, May 5, at 1:30 p.m. BST / 8:30 a.m.
Kimberly-Clark Corporation $KMB Shares Purchased by Concurrent Investment Advisors LLC
Concurrent Investment Advisors LLC increased its holdings in shares of Kimberly-Clark Corporation (NASDAQ: KMB) by 57.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,122 shares of the company's stock after acquiring an additional 7,339 shares during the quarter. Concurrent Investment Advisors
D.A. Davidson & CO. Purchases 11,660 Shares of Kimberly-Clark Corporation $KMB
D.A. Davidson and CO. increased its holdings in shares of Kimberly-Clark Corporation (NASDAQ: KMB) by 13.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 95,692 shares of the company's stock after acquiring an additional 11,660 shares during
Procter & Gamble's Portfolio Strategy: Strengthening Core Brands?
PG's innovation-led strategy drives growth, with strong product launches, brand gains and supply chain upgrades reinforcing long-term competitive advantage.
Price Targets
Kimberly-Clark price target raised to $106 from $105 at UBS
$106.00
(was $97.40)
UBS
Kimberly-Clark price target lowered to $99 from $105 at Barclays
$99.00
(was $97.09)
Lauren Lieberman
·
Barclays
Kimberly-Clark price target lowered to $100 from $110 at Wells Fargo
$100.00
(was $97.00)
Wells Fargo
Kimberly-Clark price target raised to $110 from $105 at Wells Fargo
$110.00
(was $109.41)
Wells Fargo
Kimberly-Clark price target raised to $110 from $107 at UBS
$110.00
(was $100.51)
Peter Grom
·
UBS
Kimberly-Clark price target lowered to $102 from $132 at Barclays
$102.00
(was $99.64)
Barclays
Kimberly-Clark price target lowered to $107 from $132 at UBS
$107.00
(was $98.86)
UBS
Kimberly-Clark price target lowered to $105 from $110 at Wells Fargo
$105.00
(was $98.52)
Wells Fargo
Kimberly-Clark price target lowered to $110 from $127 at BNP Paribas Exane
$110.00
(was $109.83)
BNP Paribas
Kimberly-Clark price target lowered to $125 from $144 at Morgan Stanley
$125.00
(was $99.79)
Morgan Stanley
Kimberly-Clark downgraded to In Line from Outperform at Evercore ISI
$120.00
(was $102.27)
Evercore ISI
Kimberly-Clark price target raised to $132 from $131 at Barclays
$132.00
(was $119.71)
Barclays
RBC Capital on Kimberly Clark (KMB): 'Diaper Dynamics To Impact Results'
$162.00
(was $121.45)
Nik Modi
·
RBC Capital
Kimberly-Clark price target lowered to $130 from $140 at UBS
$130.00
(was $120.80)
Peter Grom
·
UBS
Kimberly-Clark price target lowered to $145 from $149 at Piper Sandler
$145.00
(was $123.23)
Michael Lavery
·
Piper Sandler
Kimberly-Clark price target lowered to $131 from $139 at Barclays
$131.00
(was $124.34)
Barclays
Kimberly-Clark price target lowered to $156 from $158 at Piper Sandler
$156.00
(was $133.40)
Korinne Wolfmeyer
·
Piper Sandler
Kimberly-Clark price target raised to $140 from $130 at Wells Fargo
$140.00
(was $140.71)
Wells Fargo
Kimberly-Clark price target raised to $144 from $138 at Barclays
$144.00
(was $140.56)
Barclays
Kimberly Clark (KMB) PT Raised to $151 at CFRA
$151.00
(was $137.75)
Ana Garcia
·
CFRA